Search results
6 days ago · Amit Singhal is the lead investor in Trademo's latest funding round held on Nov 10, 2021.
Jun 18, 2024 · In particular, the sessions on Host-directed therapies for TB by Dr Amit Singhal (A*STAR Infectious Diseases Labs, Singapore); New therapeutic approaches against mycobacterial infections by Prof Ulrich Schaible (CEO of the Borstel Research Center, Germany); and Development of a pre-clinical TB candidate by Prof Courtney Aldrich (University of ...
Jun 20, 2024 · This paper reviews the research progress of immunotherapeutic compounds for TB, including immunoregulatory compounds and repurposing drugs, and points out the existing problems and future research directions, which lays the foundation for studying new agents for host-directed therapies of TB. Tuberculosis (TB) is a chronic bacterial disease, as well as a complex immune disease. The occurrence ...
6 days ago · Meet The GenAI Startups Putting India On The Global AI Map. 1. Observe AI. Founded in 2017 by Sharath Keshava Narayana and Swapnil Jain, Observe AI is a conversational intelligence platform for...
6 days ago · Who are the CEO, Founders and Directors of CloudGenee? Amit Singhal, Founder, is a founder of 1 company and on the board of 1 company. Sandeep Kumar Goel, Director, is on the board of 1 company. View details of CloudGenee 's Founder profiles and Board Members.
3 days ago · Saama Capital is a Venture Capital fund founded in 2006. It's primarily based out of Bengaluru, India. It has invested in 84 companies in the last 18 years with an average of 6 new investments every year in the last 10 years.
Jun 9, 2024 · Amit Singhal and Takeshi Takahashi are Co-senior authors. Authors and Affiliations. Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), 8A Biomedical Grove, Immunos #04-06, Singapore, 138648, Republic of Singapore. Teja Celhar, Xinyi Li, Yunqian Zhao, Hui Chien Tay, Andrea Lee & Amit Singhal
